An anti-IL-2 antibody increases serum halflife and improves anti-tumor efficacy of human recombinant interleukin-2

Authors:
  • JPJulia L. Phelps
    Julia L. Phelps
  • LKLinda M. Karavodin
    Linda M. Karavodin

Abstract
No abstract available

This publication has 27 references indexed in Scilit: